Is there a Bearish outlook for DENTSPLY SIRONA Inc. (NASDAQ:XRAY) this week?

January 18, 2018 - By Marie Mckinney

 Is there a Bearish outlook for DENTSPLY SIRONA Inc. (NASDAQ:XRAY) this week?
Investors sentiment increased to Infinity in Q3 2017. Its up Infinity, from 4 in 2017Q2. It is positive, as 0 investors sold DENTSPLY SIRONA Inc. shares while 0 reduced holdings. 1 funds opened positions while 5 raised stakes. 812,996 shares or 4.27% more from 779,672 shares in 2017Q2 were reported.
Eqis Mgmt has 0.02% invested in DENTSPLY SIRONA Inc. (NASDAQ:XRAY). West Oak Ltd Liability Co holds 0.82% of its portfolio in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) for 23,114 shares. Gemmer Asset Lc holds 252 shares or 0.01% of its portfolio. Cibc Ww Mkts Corporation reported 52,357 shares stake. Tirschwell Loewy reported 248,398 shares. Cardinal Mngmt owns 1.37% invested in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) for 72,544 shares. 3,651 are owned by Burney.

Since January 8, 2018, it had 0 buys, and 1 insider sale for $436,068 activity.


Among 19 analysts covering Dentsply International (NASDAQ:XRAY), 13 have Buy rating, 1 Sell and 5 Hold. Therefore 68% are positive. Dentsply International had 48 analyst reports since August 3, 2015 according to SRatingsIntel. On Thursday, August 10 the stock rating was maintained by Morgan Stanley with “Overweight”. As per Thursday, March 24, the company rating was downgraded by Morgan Stanley. Jefferies maintained DENTSPLY SIRONA Inc. (NASDAQ:XRAY) rating on Thursday, July 20. Jefferies has “Buy” rating and $7200 target. The firm has “Mkt Perform” rating given on Tuesday, February 21 by Barrington Research. The stock of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) has “Outperform” rating given on Wednesday, September 16 by Barrington Research. The stock of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) earned “Overweight” rating by Morgan Stanley on Friday, October 6. Robert W. Baird maintained the shares of XRAY in report on Friday, September 15 with “Buy” rating. On Friday, May 13 the stock rating was maintained by Barrington Research with “Outperform”. The firm has “Hold” rating by Credit Suisse given on Thursday, January 4. As per Wednesday, August 23, the company rating was maintained by Jefferies. Below is a list of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) latest ratings and price target changes.

04/01/2018 Broker: Credit Suisse Rating: Hold New Target: $73.0 Downgrade
13/12/2017 Broker: JP Morgan Old Rating: Neutral New Rating: Overweight Upgrade
13/12/2017 Broker: J.P. Morgan Rating: Buy New Target: $75.0 Upgrade
08/12/2017 Broker: Deutsche Bank Rating: Buy New Target: $81.0 Initiate
07/12/2017 Broker: H.C. Wainwright Rating: Hold New Target: $68.0 Maintain
30/11/2017 Broker: H.C. Wainwright Old Rating: Buy New Rating: Neutral Old Target: $74 Downgrade
28/11/2017 Broker: Stephens Rating: Overweight New Target: $75 Initiates Coverage On
09/11/2017 Broker: Jefferies Rating: Buy New Target: $74.0 Maintain
06/11/2017 Broker: Barrington Research Old Rating: Market Perform New Rating: Outperform Upgrade
06/11/2017 Broker: H.C. Wainwright Rating: Buy New Target: $68.0 Maintain

The stock decreased 4.57% or $3 during the last trading session, reaching $62.65. About 5.30M shares traded or 183.68% up from the average. DENTSPLY SIRONA Inc. (NASDAQ:XRAY) has risen 2.17% since January 18, 2017 and is uptrending. It has underperformed by 14.53% the S&P500.

DENTSPLY SIRONA Inc. designs, develops, makes, and markets various dental and oral health products, and other consumable healthcare products primarily for the professional dental market worldwide. The company has market cap of $14.39 billion. It operates through two divisions, Dental and Healthcare Consumables; and Technologies. It currently has negative earnings. The firm provides dental consumable products, including endodontic instruments and materials, dental anesthetics, prophylaxis pastes, dental sealants, impression materials, restorative materials, tooth whiteners, and topical fluoride products; and small equipment products comprising dental hand pieces, intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers.

More important recent DENTSPLY SIRONA Inc. (NASDAQ:XRAY) news were published by: which released: “Technical Perspectives on Medical Supplies Stocks — DENTSPLY SIRONA, Baxter …” on January 16, 2018, also published article titled: “Dentsply Sirona to Present at the 36th Annual JP Morgan Healthcare Conference”, published: “Dentsply Sirona Taps Outsider for CEO After Forced Resignations” on January 17, 2018. More interesting news about DENTSPLY SIRONA Inc. (NASDAQ:XRAY) was released by: and their article: “DENTSPLY SIRONA Inc. (XRAY) Ex-Dividend Date Scheduled for December 28, 2017” with publication date: December 27, 2017.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.